CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Efficacy of P2Y12 Reactive Unit to Predict the Periprocedural Thromboembolic and Hemorrhagic Complications According to Clopidogrel Responsiveness and Safety of Modification of Dual Antiplatelet Therapy : A Meta-Analysis
Hyun Jung Kim, Jae Sang Oh, Sukh Que Park, Seok Mann Yoon, Hyeong Sik Ahn, Bum Tae Kim
Journal of Korean Neurosurgical Society. 2020;63(5):539-549.   Published online 2019 October 30    DOI: https://doi.org/10.3340/jkns.2019.0082

Excel Download

The Efficacy of P2Y12 Reactive Unit to Predict the Periprocedural Thromboembolic and Hemorrhagic Complications According to Clopidogrel Responsiveness and Safety of Modification of Dual Antiplatelet Therapy : A Meta-Analysis
Journal of Korean Neurosurgical Society. 2020;63(5):539-549   Crossref logo
Link1 Link2 Link3

Double antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention: individual efficacy and hemorrhagic safety of P2Y12 blockers of ticagrelor and clopidogrel in actual clinical practice
Kardiologiia. 2019;59(5S):27-36   Crossref logo
Link1

CRT-100.60 The Efficacy and Safety of P2Y12 Inhibitors After a Short Course of Three Months or Less of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention and Drug-Eluting Stent Placement: A Meta-Analysis
JACC: Cardiovascular Interventions. 2020;13(4):S16   Crossref logo
Link1 Link2

Meta-analysis of the efficacy and safety of P2Y12 inhibitor monotherapy after short course of dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention
Cardiovascular Revascularization Medicine. 2020;   Crossref logo
Link1 Link2

P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis
Clinical Drug Investigation. 2020;40(9):799-808   Crossref logo
Link1 Link2 Link3

P2Y12 INHIBITOR MONOTHERAPY AFTER A SHORT DUAL ANTIPLATELET THERAPY VS. 12-MONTH DUAL ANTIPLATELET THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
Journal of the American College of Cardiology. 2020;75(11):73   Crossref logo
Link1 Link2

Abbreviated Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 12 Months’ Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
American Journal of Cardiovascular Drugs. 2019;20(4):355-361   Crossref logo
Link1 Link2 Link3

Dual antiplatelet therapy may lead to hemorrhagic complications in vitrectomy of proliferative diabetic retinopathy
Graefe's Archive for Clinical and Experimental Ophthalmology. 2018;257(2):425-426   Crossref logo
Link1 Link2 Link3

Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis
PLOS ONE. 2018;13(6):e0199232   Crossref logo
Link1

Efficacy And Safety Of P2Y12 Inhibitors In Subjects With Coronary Heart Disease Treated With Dual Anti-Platelet Therapy - A Sex-Specific Systematic Review And Meta-Analysis
Atherosclerosis. 2019;287:e143   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Korean Neurosurg Soc has participated in CrossRef Text and Data Mining service since March 1, 2015.